RSS

GNBTQ Generex Biotechnology Corp.

Mod: rjs9787 Asst: docj
Last Post: 10/16/26
Followers: 122
Posts Today: 0
Views Today: 2048

GNBTQ Stock Quote & Tools

$0.0000 ▲ +0.0000 (+0.00%) As of Jan 25, 4:00 PM
Last0.0000
$ Chg0.0000
Open—
High—
Beta0.5408
Year High—
Market Cap—
P/B Ratio-0.54
EPS—
Avg Vol (30d)0
Volume—
% Chg+0.00%
Prev Close0.0000
Low—
VWAP0.00000
Year Low—
Total Shares118.45M
Shares Out118.45M
Float116.37M
Exchange
Healthcare Biotechnology & Life Sciences

GNBTQ Stock Message Board Discussion

  1. BallFan
  2. rjs9787
  3. Beasley

Top 10 Most Recent News Articles

JELD-WEN Schedules Q3 2026 Earnings Call Amid Global Reach

Updated Category News Views 13

Looking Ahead: JELD-WEN's Q3 Results Exploration Alright folks, buckle up. JELD-WEN Holding, Inc., the name any DIY'er worth their salt recognizes for doors and windows, has set the stage for unveiling its third quarter 2026 performance. They've earmarked November 3 post-market for us to comb through the numbers, and they're wasting no time by getting on a conference call...

Continue Reading
King City Gardens Debuts Third Dispensary in Cincinnati

Updated Category News Views 3

Every corner of Cincinnati’s cannabis scene just got a little busier with King City Gardens opening up shop in Colerain Township. This move marks their third Garden Dispensary in Greater Cincinnati. It’s not just about adding another location, though. It’s King City’s way of cementing their local roots deeper into the city’s soil, rolling out a mix of...

Continue Reading
Call to Action: Make Disease Cure the Top Election Issue

Updated Category News Views 8

A Call for Congressional Accountability The American Center for Cures is banging the drum for change, and they're banging it loud. Founded by Lou Weisbach, this group has come out swinging, urging Americans to slap disease onto the ballot in the midterms. Why? Because dealing with Alzheimer's, diabetes, heart disease, and cancer every year rips a whopping $1.1 trillion...

Continue Reading
Hyliion Partnership Woes: Investors Eye Legal Options

Updated Category News Views 6

Hyliion's Rocky Partnership Sparks Market Concern If you've got your cash tied up in Hyliion Holdings Corp. (NYSE: HYLN), you've probably got an eye twitch by now. Last June, a damning report from Pelican Way Research threw a wrench in Hyliion's plans with VFG Holdings, calling into question the whole commercial rationale of their newest partnership. Imagine staking $133...

Continue Reading
FMC's Holiday Classics Marathon Returns October 25th

Updated Category News Views 6

Classic Films Ring in the Holidays Again FMC is prepping the screens with something that has folks nostalgic for the golden era of film. This year, starting October 25th, their famous "Silver Bells & Silver Screens" is set to light up the nightly schedule with holiday classics that never fail to remind you of cozy winters by the fire. These aren't just movies—they're...

Continue Reading
PG&E Delivers $26M Climate Credit to Small Biz

Updated Category News Views 11

California's Big Move for Small Businesses In a world where every dollar counts, small businesses across Northern and Central California are getting a helping hand. Pacific Gas and Electric Company (PG&E) is stepping up with a tidy little climate credit thanks to the state's Cap-and-Invest Program. Eligible businesses are automatically set to receive a $36.18 credit off...

Continue Reading
Duolingo Faces Investor Legal Battle Over Stock Decline

Updated Category News Views 11

Doughnut-Sized Dilemma for Duolingo Investors Falling stock prices are nothing new, but when Duolingo (NASDAQ: DUOL) tumbles 25.49% and a securities fraud class action tags along, eyebrows raise. Folks invested between May 2, 2025, and February 26, 2026, might want to dig deeper. Why? Because the alleged deception has unraveled any potential optimism these shareholders...

Continue Reading
Long March Unity: Defying Odds with Shared Conviction

Updated Category News Views 0

Unlikely Unity Amidst Adversity Imagine facing a path so treacherous that every step could mean your last. That was the Long March for the Red Army—a grueling test not just of endurance, but of unity. This is the kind of story that makes you sit up and think about what drives people to stick together when everything is falling apart. The Red Army faced hellish...

Continue Reading
AppLovin Faces Lawsuit Over AI Claims: Investor Alert

Updated Category News Views 5

AI Promises or Pipedreams? AppLovin Corporation finds itself in a bit of hot water, and if you've got skin in this game, you've probably felt the heat. So, what's stirring the pot? A class action lawsuit against AppLovin (NASDAQ: APP) for allegedly pulling the wool over investors' eyes with overstated claims about their generative AI tool. Class Action: Weighing the...

Continue Reading
Life After Debt: Freedom, Confidence, and Wellbeing

Updated Category News Views 9

The Unseen Upside of Financial Freedom Debt can feel like a ball and chain, dragging down everything from your sleep to your relationships. But shred that debt, and suddenly the world looks different. Accredited Debt Relief's recent survey of 1,000 folks who've paid off at least $5,000 in unsecured debt uncovers the remarkable transformations that follow. According to 93%...

Continue Reading

Top 5 Most Recently Viewed Articles

Vistin Pharma ASA Welcomes Stakeholders to Q3 Results Call

Updated Category News Views 68

Join Vistin Pharma ASA's Q3 2024 Conference Call Vistin Pharma ASA, a prominent player in the pharmaceutical landscape, is gearing up to share its performance metrics for the third quarter of 2024. Scheduled for October 31, 2024, this event marks an essential touchpoint for shareholders and interested stakeholders looking to understand the company’s financial health and...

Continue Reading
SkiStar Unveils Annual and Sustainability Insights for 2023/24

Updated Category News Views 201

Introduction to SkiStar's Annual Report SkiStar AB (publ) has unveiled its Annual and Sustainability Report for the financial year 2023/24, a comprehensive document reflecting its ongoing commitment to transparency and sustainability in mountain tourism. This significant report can be accessed on SkiStar’s official webpage. Report Availability and Compliance The Swedish...

Continue Reading
Qualigen Therapeutics Faces Nasdaq Notification Over Delayed Filing

Updated Category News Views 179

Qualigen Therapeutics Confronts Important Nasdaq Notification Qualigen Therapeutics, Inc. (NASDAQ: QLGN), has recently issued a statement regarding a notable event concerning its financial filings. The company received a notification from the Nasdaq Stock Market indicating a deficiency primarily related to the delayed submission of its quarterly report on Form 10-Q for...

Continue Reading
RBA Earnings Preview: What Traders Should Watch For

Updated Category News Views 132

RB Global (NYSE:RBA) is gearing up for its quarterly earnings reveal, and the stakes are high. Analysts are eyeing an earnings per share (EPS) of $0.97, which sets the stage for a tense showdown between expectation and reality. Earnings History: A Glimpse into Performance Last quarter was a win for RB Global; they surpassed EPS expectations by $0.13, leading to a 4.36%...

Continue Reading
UK Considers Major Drug Price Increases Amid Pharma Migration

Updated Category News Views 203

UK Drug Pricing Adjustments on the Horizon In a significant development, UK ministers are preparing to increase the payments made by the National Health Service for medicinal products by up to 25%. This proposal comes after intensive discussions with pharmaceutical companies, occurring alongside pressures to realign drug prices with international standards and address the...

Continue Reading